I was simply pointing out that your ‘analysis’ is myopic and you’re not credible. We are more interested in verifiable and credentialed sources of analyses, such as licensed physicians and independently peer-reviewed literature. Grant funding also provides us with reliable peer-reviewed analyses as clinical studies advance through stages of clinical investigation while under continuous peer-review.
Here’s a follow-up to the earlier discussion about the cell and gene products that are already approved and commercialized… and their relevance to dendritic cell platforms..